Literature DB >> 25225453

Carbamidocyclophanes F and G with Anti-Mycobacterium tuberculosis Activity from the Cultured Freshwater Cyanobacterium Nostoc sp.

Shangwen Luo1, Hahk-Soo Kang1, Aleksej Krunic1, George E Chlipala1, Geping Cai2, Wei-Lun Chen1, Scott G Franzblau2, Steven M Swanson1, Jimmy Orjala1.   

Abstract

Two new (1 and 2) and three known (3-5) carbamidocyclophanes were isolated from a cultured freshwater cyanobacterium Nostoc sp. (UIC 10274) obtained from a sample collected at Des Plaines, Illinois. Their planar structures and stereoconfigurations were determined by extensive spectroscopic analysis including 1D/2D NMR experiments, HRESIMS as well as CD spectroscopy. Carbamidocyclophane F (1) showed potent anti-Mycobacterium tuberculosis activity in the microplate Alamar blue assay and low-oxygen-recovery assay with MIC values of 0.8 and 5.4 µM, respectively. Carbamidocyclophane F (1) also displayed antimicrobial activities against the gram positive bacteria Staphylococcus aureus and Enterococcus faecalis with MIC values of 0.1 and 0.2 µM, respectively. Carbamidocyclophane F (1) and Carbamidocyclophane G (2) both showed antiproliferative activity against MDA-MB-435 and HT-29 human cancer cell lines with IC50 values in the range from 0.5 to 0.7 µM.

Entities:  

Keywords:  Anti- Mycobacterium tuberculosis Activity; Cyanobacteria; Nostoc sp.; [7.7]paracyclophane

Year:  2014        PMID: 25225453      PMCID: PMC4161986          DOI: 10.1016/j.tetlet.2013.11.112

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  8 in total

Review 1.  The future challenges facing the development of new antimicrobial drugs.

Authors:  Anthony Coates; Yanmin Hu; Richard Bax; Clive Page
Journal:  Nat Rev Drug Discov       Date:  2002-11       Impact factor: 84.694

2.  Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay.

Authors:  S G Franzblau; R S Witzig; J C McLaughlin; P Torres; G Madico; A Hernandez; M T Degnan; M B Cook; V K Quenzer; R M Ferguson; R H Gilman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

3.  Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.

Authors:  Sang Hyun Cho; Saradee Warit; Baojie Wan; Chang Hwa Hwang; Guido F Pauli; Scott G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

4.  Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.

Authors:  L Collins; S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

5.  Cylindrocyclophanes with proteasome inhibitory activity from the Cyanobacterium Nostoc sp.

Authors:  George E Chlipala; Megan Sturdy; Aleksej Krunic; Daniel D Lantvit; Qi Shen; Kyle Porter; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2010-09-24       Impact factor: 4.050

6.  Carbamidocyclophanes A-E, chlorinated paracyclophanes with cytotoxic and antibiotic activity from the Vietnamese cyanobacterium Nostoc sp.

Authors:  Ha T N Bui; Rolf Jansen; Hang T L Pham; Sabine Mundt
Journal:  J Nat Prod       Date:  2007-02-21       Impact factor: 4.050

7.  Cylindrocyclophane biosynthesis involves functionalization of an unactivated carbon center.

Authors:  Hitomi Nakamura; Hilary A Hamer; Gopal Sirasani; Emily P Balskus
Journal:  J Am Chem Soc       Date:  2012-11-02       Impact factor: 15.419

8.  Merocyclophanes A and B, antiproliferative cyclophanes from the cultured terrestrial Cyanobacterium Nostoc sp.

Authors:  Hahk-Soo Kang; Bernard D Santarsiero; Hyunjung Kim; Aleksej Krunic; Qi Shen; Steven M Swanson; Heebyung Chai; A Douglas Kinghorn; Jimmy Orjala
Journal:  Phytochemistry       Date:  2012-05-07       Impact factor: 4.072

  8 in total
  15 in total

1.  Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045.

Authors:  Shangwen Luo; Hahk-Soo Kang; Aleksej Krunic; Wei-Lun Chen; Jilai Yang; John L Woodard; James R Fuchs; Sang Hyun Cho; Scott G Franzblau; Steven M Swanson; Jimmy Orjala
Journal:  Bioorg Med Chem       Date:  2015-05-01       Impact factor: 3.641

Review 2.  Discovery of Anticancer Agents of Diverse Natural Origin.

Authors:  A Douglas Kinghorn; Esperanza J Carcache DE Blanco; David M Lucas; H Liva Rakotondraibe; Jimmy Orjala; D Doel Soejarto; Nicholas H Oberlies; Cedric J Pearce; Mansukh C Wani; Brent R Stockwell; Joanna E Burdette; Steven M Swanson; James R Fuchs; Mitchell A Phelps; Lihui Xu; Xiaoli Zhang; Young Yongchun Shen
Journal:  Anticancer Res       Date:  2016-11       Impact factor: 2.480

3.  Anti-MRSA-acting carbamidocyclophanes H-L from the Vietnamese cyanobacterium Nostoc sp. CAVN2.

Authors:  Michael Preisitsch; Kirsten Harmrolfs; Hang T L Pham; Stefan E Heiden; Anna Füssel; Christoph Wiesner; Alexander Pretsch; Monika Swiatecka-Hagenbruch; Timo H J Niedermeyer; Rolf Müller; Sabine Mundt
Journal:  J Antibiot (Tokyo)       Date:  2014-09-03       Impact factor: 2.649

4.  Merocyclophanes C and D from the Cultured Freshwater Cyanobacterium Nostoc sp. (UIC 10110).

Authors:  Daniel S May; Wei-Lun Chen; Daniel D Lantvit; Xiaoli Zhang; Aleksej Krunic; Joanna E Burdette; Alessandra Eustaquio; Jimmy Orjala
Journal:  J Nat Prod       Date:  2017-03-02       Impact factor: 4.050

5.  Microseiramide from the Freshwater Cyanobacterium Microseira sp. UIC 10445.

Authors:  Shangwen Luo; Aleksej Krunic; George E Chlipala; Jimmy Orjala
Journal:  Phytochem Lett       Date:  2015-09-01       Impact factor: 1.679

6.  Discovery of Anticancer Agents of Diverse Natural Origin.

Authors:  Leslie N Aldrich; Joanna E Burdette; Esperanza Carcache de Blanco; Christopher C Coss; Alessandra S Eustaquio; James R Fuchs; A Douglas Kinghorn; Amanda MacFarlane; Brittney K Mize; Nicholas H Oberlies; Jimmy Orjala; Cedric J Pearce; Mitch A Phelps; Liva Harinantenaina Rakotondraibe; Yulin Ren; Djaja Doel Soejarto; Brent R Stockwell; Jack C Yalowich; Xiaoli Zhang
Journal:  J Nat Prod       Date:  2022-02-25       Impact factor: 4.803

7.  Ribocyclophanes A-E, Glycosylated Cyclophanes with Antiproliferative Activity from Two Cultured Terrestrial Cyanobacteria.

Authors:  Daniel S May; Hahk-Soo Kang; Bernard D Santarsiero; Aleksej Krunic; Qi Shen; Joanna E Burdette; Steven M Swanson; Jimmy Orjala
Journal:  J Nat Prod       Date:  2018-01-30       Impact factor: 4.050

8.  A new strategy for aromatic ring alkylation in cylindrocyclophane biosynthesis.

Authors:  Hitomi Nakamura; Erica E Schultz; Emily P Balskus
Journal:  Nat Chem Biol       Date:  2017-06-26       Impact factor: 15.040

9.  The impact of culture conditions on growth and metabolomic profiles of freshwater cyanobacteria.

Authors:  Camila M Crnkovic; Daniel S May; Jimmy Orjala
Journal:  J Appl Phycol       Date:  2017-09-14       Impact factor: 3.215

Review 10.  Biological Activity of Recently Discovered Halogenated Marine Natural Products.

Authors:  Gordon W Gribble
Journal:  Mar Drugs       Date:  2015-06-30       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.